Bristol-Myers Squibb Co
XHAM:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
XHAM:BRM
|
US |
|
Liberty Media Corp
NASDAQ:LSXMK
|
US |
|
Perrigo Company PLC
F:PIG
|
IE |
|
Fortescue Metals Group Ltd
F:FVJA
|
AU |
|
J
|
JPMorgan Chase & Co
BMV:JPM
|
US |
|
T
|
Takkt AG
XHAM:TTK
|
DE |
|
P
|
PepsiCo Inc
SIX:PEP
|
US |
|
S
|
Southern Co
XMUN:SOT
|
US |
|
S
|
Subsea 7 SA
XBER:SOC
|
UK |
|
G
|
Goldman Sachs Group Inc
XBER:GOS
|
US |
|
A
|
America Movil SAB de CV
F:MV9
|
MX |
|
F
|
FIH Mobile Ltd
HKEX:2981
|
TW |
|
Airbus SE
OTC:EADSY
|
NL |
|
Kinovo PLC
F:0D6
|
UK |
|
S
|
Sands China Ltd
XMUN:599A
|
MO |
|
B
|
Bio-Techne Corp
F:TE1
|
US |
|
H
|
Henry Schein Inc
F:HS2
|
US |
|
Nextera Energy Inc
NYSE:NEE
|
US |
|
P
|
Pagegroup PLC
OTC:MPGPF
|
UK |
|
Deutsche Telekom AG
MIL:DTE
|
DE |
|
H
|
Hess Corp
XBER:AHC
|
US |
|
Pirelli & C SpA
F:2PI
|
IT |
|
F
|
Fulton Financial Corp
F:FU5
|
US |
|
Essity AB (publ)
F:ESWB
|
SE |
Bankruptcy Probability
Bristol-Myers Squibb Co's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Bristol-Myers Squibb Co Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
919.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
535.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
358.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
277.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
206.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
108B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
58.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Bristol-Myers Squibb Co's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Bristol-Myers Squibb Co has total debt of 42.5B USD. This includes both short-term (319m USD) and long-term (42.2B USD) debt.
You can find a full breakdown on its Balance Sheet.
